New medicines from Gilead Sciences Inc., Roche Holding AG, Pharmacyclics Inc. and others are poised to reshape treatment of the most common form of leukemia among adults, potentially eliminating chemotherapy from regimens and extending patients’ lives.
Human immune cells reprogrammed in the laboratory to attack leukemia helped drive out the blood cancer in adults and children with aggressive forms of the disease, according to studies on the new strategy.
The U.S. Securities and Exchange Commission is weighing whether proxy advisers have grown so influential in corporate elections that regulators should impose rules to make their business more transparent.
Just after midnight one sultry Friday in August 1987, Manila became a battleground as rebel troops attempted a coup against Philippine President Corazon Aquino. Two blocks from the besieged presidential palace, insurgents opened fire on a car carrying Aquino’s only son, a bespectacled and soft-spoken 27-year-old junior insurance executive nicknamed Noynoy.
Neel Kashkari, the former Goldman Sachs Group Inc. executive chosen by ex-Treasury Secretary Henry Paulson to help rescue the U.S. banking system, is readying a challenge to California Governor Jerry Brown even as the world’s 10th-largest economy reaches its highest level in more than three decades.
Apple Inc.’s stunning new Campus 2 in Cupertino, California, will be one of Steve Jobs’ lasting legacies when completed in 2015. For better or worse, he was thinking differently to the end, striving for geographic self- sufficiency even as many other high-technology enterprises across the country were starting to return to city life. Will this approach, and the complex that embodies it, renew Apple’s culture of excellence or retard it?
U.S. corporations are switching chief executive officers at the fastest pace in five years as companies from Wal-Mart Stores Inc. to Microsoft Corp. grapple with shifting customer tastes, competition from upstarts and restive shareholders.